Full Text
PCN28 COST-UTILITY ANALYSIS IN A SPANISH SETTING OF ADJUVANT THERAPY WITH TRASTUZUMAB (HERCEPTIN) IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER

Abstract

Authors

C Polanco M Carulla X Badia A Ramirez-Arellano

Back to Volume 11, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×